Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.
Centro Nacional de Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain.
Mol Metab. 2021 Aug;50:101190. doi: 10.1016/j.molmet.2021.101190. Epub 2021 Feb 13.
Non-alcoholic fatty liver disease (NAFLD) is an important component of metabolic syndrome and one of the most prevalent liver diseases worldwide. This disorder is closely linked to hepatic insulin resistance, lipotoxicity, and inflammation. Although the mechanisms that cause steatosis and chronic liver injury in NAFLD remain unclear, a key component of this process is the activation of stress-activated kinases (SAPKs), including p38 and JNK in the liver and immune system. This review summarizes findings which indicate that the dysregulation of stress kinases plays a fundamental role in the development of steatosis and are important players in inducing liver fibrosis. To avoid the development of steatohepatitis and liver cancer, SAPK activity must be tightly regulated not only in the hepatocytes but also in other tissues, including cells of the immune system. Possible cellular mechanisms of SAPK actions are discussed.
非酒精性脂肪性肝病 (NAFLD) 是代谢综合征的一个重要组成部分,也是全球最常见的肝脏疾病之一。这种疾病与肝胰岛素抵抗、脂毒性和炎症密切相关。虽然导致 NAFLD 中脂肪变性和慢性肝损伤的机制尚不清楚,但该过程的一个关键组成部分是应激激活激酶 (SAPKs) 的激活,包括肝脏和免疫系统中的 p38 和 JNK。本综述总结了一些发现,这些发现表明应激激酶的失调在脂肪变性的发展中起着根本性的作用,并且是诱导肝纤维化的重要因素。为了避免脂肪性肝炎和肝癌的发展,SAPK 活性不仅必须在肝细胞中而且还必须在其他组织中受到严格调节,包括免疫系统的细胞。讨论了 SAPK 作用的可能细胞机制。